Ray Dalio United Therapeutics Corp Transaction History
Bridgewater Associates, LP
- $21.1 Billion
- Q4 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in United Therapeutics Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 107,730 shares of UTHR stock, worth $33.2 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
107,730
Previous 61,755
74.45%
Holding current value
$33.2 Million
Previous $22.1 Million
71.77%
% of portfolio
0.18%
Previous 0.13%
Shares
19 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
61MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$5.65 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.37 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$852 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$760 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...